Evaluation of efficacy of Lactogum and coldanese on prevention of flu-like symptoms

Phase 3

• Conditions: Condition 1: Fever of other and unknown origin. Condition 2: Diarrhea. Condition 3: pharyngitis. Condition 4: Cough. Condition 5: rhinitis. Condition 6: Nausea and vomiting. Condition 7: flu-like symptoms.; Fever of other and unknown origin; Diarrhea, unspecified; Acute pharyngitis, unspecified; Cough; Vasomotor and allergic rhinitis; Nausea and vomiting; Influenza due to unidentified influenza virus with other respiratory manifestations; R19.7; J02.9

• Registration Number: IRCT20231214060363N1
• Lead Sponsor: afs zist Farmed Company

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 22 July 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 2000

Inclusion Criteria

age range was 16 to 70 years old
healthcare workers and members of therapeutic Mawkibs

Exclusion Criteria

Severe cardiovascular, endocrinological, respiratory, and gastrointestinal diseases
Pregnancy
Irritable bowel syndrome, active ulcerative colitis, or short bowel syndrome
Known hypersensitivity or allergy to any component of the test products
Severe deviation of the nasal septum, presence of nasal polyps, or other non-infectious conditions leading to nasal blockage
Recent treatment of the common cold that, in the opinion of the investigator, may influence symptoms
Immunodeficiency

Study & Design

• Study Type: interventional
• Study Design: Not specified